The University of Connecticut has announced a new stem cell research collaboration in the field of rare disease with Cheshire, Conn.-based Alexion Pharmaceuticals Inc. . The research collaboration will focus on the discovery and testing of therapeutic candidates to treat rare and disabling disorders for which there are currently no effective treatments.
http://ift.tt/1CcmD6e
http://ift.tt/1CcmD6e
No comments:
Post a Comment